WIPO logo
모바일 | Deutsch | English | Español | Français | 日本語 | Português | Русский | 中文 | العربية |
PATENTSCOPE

국제 및 국내 특허문헌 검색
World Intellectual Property Organization
검색
 
열람
 
번역
 
옵션
 
뉴스
 
로그인
 
도움말
 
검색결과 133,480 1-10 검색기준: CTR:sg 특허청: all 언어: KO 어간추출: true maximize
이전 1 2 3 4 5 6 7 8 9 10 다음
Page: / 13349 Go >
RSS iconmap icon 
Instant Help

검색결과의 분석
검색결과의 분석

목록 길이
기계 번역
발명의 명칭국가공개일
국제특허분류출원번호출원인발명자
1. 11201706398V RECOMBINANT PROBIOTIC BACTERIASG28.09.2017
A61K 38/17
11201706398VAUREALIS OYWIRTH, Thomas
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 11 August 2016 (11.08.2016) WIPOIPCT (10) International Publication Number WO 2016/124266 A1 (51) International Patent Classification: A61K38/17 (2006.01) A61K35/74 (2015.01) A61K39/02 (2006.01) A61P17/00 (2006.01) A61K 9/16 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: PCT/EP2015/075484 2 November 2015 (02.11.2015) English (30) Priority Data: PCT/EP2015/052345 4 February 2015 (04.02.2015) English EP (71) Applicant: AUREALIS OY [FI/FI]; Microkatu 1, FI- 70210 Kuopio (FI). (72) Inventors: WIRTH, Thomas; Ritosentie 20 C 15, FI- 70340 Kuopio (FI). YRJANHEIKKI, Juha; Renkitie 20, FI-70820 Kuopio (FI). SAMARANAYAKE, Haritha; Metsurintie 11 B 34, FI-70150 Kuopio (FI). (74) Agent: WALCHER, Armin; Louis Pohlau Lohrentz, Pat- entanwalte, Zusammenschluss Nr. 39, Postfach 30 55, 90014 Niirnberg (DE). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) — with sequence listing part of description (Rule 5.2(a)) V© CJ •t CJ i-H o CJ (54) Title: RECOMBINANT PROBIOTIC BACTERIA (57) Abstract: The invention is directed to recombinant probiotic bacteria, especially for use in the treatment of an inflammatory skin dysfunction, as well as a method for treating an inflammatory skin dysfunction.

2. 11201706400W DERMATOPONTIN AS A THERAPEUTIC FOR METABOLIC DISORDERSSG28.09.2017
A61K 38/17
11201706400WAGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCHHONG, Wanjin
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 18 August 2016 (18.08.2016) WIPOIPCT (10) International Publication Number WO 2016/130085 A1 (51) International Patent Classification: A61K 38/17 (2006.01) A61P 9/00 (2006.01) A61P 3/00 (2006.01) G01N33/68 (2006.01) (21) International Application Number: PCT/SG2016/050066 (22) International Filing Date: 11 February 2016 (11.02.2016) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 10201501053Q 11 February 2015 (11.02.2015) SG (71) Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH [SG/SG]; 1 Fusionopolis Way, #20-10 Connexis, Singapore 138632 (SG). (72) Inventors: HONG, Wanjin; c/o Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore 138673 (SG). TAN, Shixiong; c/o Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore 138673 (SG). HAN, Weiping; c/o Singapore Bioimaging Consortium, 11 Biopolis Way, #01-02, Helios Building, Singapore 138667 (SG). (74) Agent: SPRUSON & FERGUSON (ASIA) PTE LTD; P.O. Box 1531, Robinson Road Post Office, Singapore 903031 (SG). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). [Continued on next page] (54) Title: DERMATOPONTIN AS A THERAPEUTIC FOR METABOLIC DISORDERS FIG. 1 oo o o m i-H v© i-H o CJ o & •increase body weight "mtmsass h;;viy 5ai; giucass efe*mr*e» resistance •wwer memtM m poay -Issss body M •better gSuKssss eSaarsi'K® •-sTHir® tesisfe sassifee -Increase eti«?gy sxpsncM&ire -msisboiically satte' ssff (57) Abstract: The present disclosure describes to a method of treating a metabolic disease in a subject, wherein the meth­ od comprises administration of dermatopontin to a subject, wherein the dermatopontin is recombinant dermatopontin and the metabolic disease is selected from a group consisting of weight gain, diet-induced weight gain, obesity, morbid obesity, metabolic syndrome, glucose homeostasis, insulin resistance, type I diabetes, type if diabetes and cardiovascular disease. Disclosed herein is also a method of determining or making a prognosis of a subject's susceptibility to metabolic diseases and obesity, the method comprising measuring the level of circulating dermatopontin in a sample obtained from a subject; and comparing the level of circulating dermato­ pontin obtained with the level of dermatopontin previously determined in a control; and determining the susceptibility of the subject to metabolic disease and obesity based on the dif­ ference between the level of circulating dermatopontin and the level of dermatopontin in the control. WO 2016/130085 A11 lllll llllllll II llllll III lllll lllll III III III lllll lllll lllll lllll lllll llll lllllll llll llll llll Declarations under Rule 4.17: Published: — ofinventorship (Rule 4.17(iv)) — with international search report (Art. 21(3)) — with sequence listing part of description (Rule 5.2(a))

3. 11201706402Y ONE-SIDE-PROTECTED POLARIZING FILM, PRESSURE-SENSITIVE-ADHESIVE-LAYER-ATTACHED POLARIZING FILM, IMAGE DISPLAY DEVICE, AND METHOD FOR CONTINUOUSLY PRODUCING SAMESG28.09.2017
C09J 201/00
11201706402YNITTO DENKO CORPORATIONXU, Jingfan

4. 11201706410X USER TERMINAL, WIRELESS BASE STATION AND WIRELESS COMMUNICATION METHODSG28.09.2017
H04W 72/12
11201706410XNTT DOCOMO, INC.HARADA, Hiroki
51 USER TERMINAL, RADIO BASE STATION, AND RADIO COMMUNICATION METHOD ABSTRACT present is to adequate 5 even the of that be in user is expanded that existing and/or CA executed unlicensed user communicates a base by of aggregation a of carriers (CCs), and has a receiving section that receives DL signals transmitted from 10 each a section transmits signals, a section controls operations the section, and, a of including least first which corresponds to a primary CC of an existing system, and a third CC, which is different from the first CC and a second CC that corresponds to a secondary 15 CC of the existing system, are configured, the control section applies, to the third CC, UL signal transmission operations that are different from those of the second CC. Fig. 5 20

5. 11201706411Y SUBSTITUTED PYRAZOLE COMPOUNDS AS SERINE PROTEASE INHIBITORSSG28.09.2017
A61K 31/4155
11201706411YVERSEON CORPORATIONSHORT, Kevin Michael
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 1 September 2016 (01.09.2016) WIPOIPCT (10) International Publication Number WO 2016/138532 A1 (51) International Patent Classification: A61K31/4155 (2006.01) C07D 401/04 (2006.01) C07D 231/02 (2006.01) (21) International Application Number: PCT/US2016/020116 (22) International Filing Date: 29 February 2016 (29.02.2016) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/126,424 27 February 2015 (27.02.2015) US (71) Applicant: VERSEON CORPORATION [US/US]; 48820-100B Kato Rd., Fremont, California 94538 (US). (72) Inventors: SHORT, Kevin Michael; c/o Verseon Corpor­ ation, 48820-100B Kato Rd., Fremont, California 94538 (US). ESTIARTE-MARTINEZ, Maria de los Angeles; c/o Verseon Corporation, 48820-100B Kato Rd., Fremont, California 94538 (US). KITA, David Ben; c/o Verseon Corporation, 48820-100B Kato Rd., Fremont, California 94538 (US). SHIAU, Timothy Philip; c/o Verseon Cor­ poration, 48820-100B Kato Rd., Fremont, California 94538 (US). (74) Agents: VAGNER, Allison et al.; c/o IP Docketing De­ partment, Davis Wright Tremaine LLP, 1201 Third Avenue Suite 2200, Seattle, Washington 98101-3045 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: — as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(H)) — as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) Published: — with international search report (Art. 21(3)) CJ oo i-H o CJ (54) Title: SUBSTITUTED PYRAZOLE COMPOUNDS AS SERINE PROTEASE INHIBITORS (57) Abstract: There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of thrombin and/or kal- likrein, which compounds include substituted pyrazolyl. There are additionally provided pharmaceutical compositions. There are ad­ ditionally provided methods of treating and preventing certain diseases or disorders, which diseases or disorders are amenable to treatment or prevention by the inhibition of thrombin and/or kallikrein.

6. 11201706413U WIRELESS COMMUNICATION APPARATUS AND WIRELESS COMMUNICATION METHODSG28.09.2017
H04J 11/00
11201706413UPANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.HUANG, Lei
47 WIRELESS COMMUNICATION DEVICE AND WIRELESS COMMUNICATION METHOD ABSTRACT A wireless communication device serving as an NG60 WiGig device includes a PPDU generator that generates an MF control PHY PPDU (physical layer protocol data unit) including a legacy preamble, a legacy header, an NG60 header (a non-legacy header), a data field, and identification information indicating that the non-legacy header is included and a transmitter that transmits the generated MF control PHY PPDU. Figure 14

7. 11201706415V COMPOSITION CONTAINING MIXTURE OF FLUORINATED HYDROCARBONS, AND METHOD FOR PRODUCING SAMESG28.09.2017
C09K 5/04
11201706415VDAIKIN INDUSTRIES, LTD.ITANO, Mitsushi
-29- COMPOSITION CONTAINING MIXTURE OF FLUORINATED HYDROCARBONS, AND METHOD FOR PRODUCING SAME ABSTRACT 5 This invention provides, as alternative refrigerants for R404A, a refrigerant and refrigerant composition that have, for example, a nonflammability similar to that of R404A, a refrigerating capacity that can replace that of R404A, a ratio of 10 refrigerating capacity to power consumed in a refrigeration cycle (coefficient of performance (COP)) that is equal or superior to that of R404A, and a lower GWP than that of R404A. More specifically, this invention provides a composition comprising a mixture containing fluorinated 15 hydrocarbons, the composition ratio of the fluorinated hydrocarbons contained in the mixture falling within a triangle having the following three points as vertices in a ternary composition diagram in which the sum of the concentrations of difluoromethane (R32), pentafluoroethane (R125), and 1,1,1,2- 20 tetrafluoroethane (R134a) is 100 wt%: point A (R32/R125/R134a = 37.3/17.0/45.7 wt%), point F (R32/R125/R134a = 30.7/10.9/58.4 wt%), and point G (R32/R125/R134a = 29.4/14.1/56.5 wt%). 25 [Fig. 1]

8. 11201706419W DEHUMIDIFICATION/HUMIDIFICATION DEVICESG28.09.2017
F24F 6/00
11201706419WSHARP KABUSHIKI KAISHATAKAMOTO Daiki
- 28 - ABSTRACT Provided is a dehumidification/humidification device (A) including a cabinet (1) having a first inlet port (16), a second inlet port (17), and a blowout port (15); a first air duct (R1) leading from the first inlet port (16) to the blowout port (15); a second air duct (R2) leading from the second inlet port (17) to the blowout port (15); a humidification unit (5) that is provided within either the first air duct (R1) or the second air duct (R2), a dehumidification unit (4) that is provided within the other air duct, and a blower (2) that generates an air flow within each of the first air duct (R1) and the second air duct (R2).

9. 11201706420S PEPTIDES HAVING AFFINITY FOR POLYDIMETHYLSILOXANE, AND USES THEREOFSG28.09.2017
C07K 17/08
11201706420SNATIONAL UNIVERSITY CORPORATION KYOTO INSTITUTE OF TECHNOLOGYKUMADA, Yoichi
52 ABSTRACT An object of the present invention is to provide a polydimethylsiloxane substrate to which a peptide having an affinity for polydimethylsiloxane (PDMS) is bound; a method for immobilizing a target protein on apolydimethylsiloxane 5 substrate ; a p eptide having an affinity for PDMS ; a polynucleotide encoding a p eptide having an affinity for PDMS ; and a vector using thereof. A pol ydimethylsiloxane substrate to which a peptide having an affinity for polydimethylsiloxane is bound, the peptide comprising the following peptide (1 a ) or (1 b ) , 10 or a fragment thereof: (1 a ) a peptide comprising an amino acid sequence represented by at least one member selected from the group consisting of SEQ ID NO s : 1 to 9 ;and (1 b ) a peptide compri sing the amino acid sequence of ( 1a )in which one or more amino acids are deleted, substituted, and/ or added , the peptide 15 having an affinity for polydimethylsilo xane . 20

10. 11201706421V METHODS AND A COMPUTING DEVICE FOR DETERMINING WHETHER A MARK IS GENUINESG28.09.2017
G06K 9/46
11201706421VSYS-TECH SOLUTIONS, INC.SOBORSKI, Michael, L.
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 25 August 2016 (25.08.2016) WIPOIPCT (10) International Publication Number WO 2016/133564 A1 (51) International Patent Classification: G06K 9/46 (2006.01) G06K19/06 (2006.01) (21) International Application Number: PCT/US2015/058620 (22) International Filing Date: (25) Filing Language: (26) Publication Language: 2 November 2015 (02.11.2015) English English (30) Priority Data: 14/623,925 17 February 2015 (17.02.2015) US (71) Applicant: SYS-TECH SOLUTIONS, INC. [US/US]; One Research Way, Princeton, NJ 08540 (US). (72) Inventor: SOBORSKI, Michael, L.; 8 Philip Court, Al- lentown, NJ 08501 (US). (74) Agents: WULFF, Richard, A. et al.; Drinker Biddle & Reath LLP, 191 N. Wacker Drive, Suite 3700, Chicago, IL 60606-1698 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) (54) Title: METHODS AND A COMPUTING DEVICE FOR DETERMINING WHETHER A MARK IS GENUINE 100 104 Mark-Applying Device Legitimate Physical Object Genuine Mark h 102 First Image- Capturing Device First Computing Device First Image- Capturing Device First Computing Device r o Second Computing Device 118 Second Image Third Computing Capturing Device Device (57) Abstract: The present disclosure is gener­ ally directed to a method and computing device for determining whether a mark is genuine. According to various embodiments, a computing device (or logic circuitry thereof) uses unintentionally-produced artifacts within a genuine mark to define an identifiable elec­ tronic signature, and extracts certain location identifiers corresponding to certain measured features of the signature in order to enhance the ease and speed with which numerous genu­ ine signatures can be searched and compared with signatures of candidate marks. •t FIG. 1 i-H o CJ o &


검색결과 133,480 1-10 검색기준: CTR:sg 특허청: all 언어: KO 어간추출: true maximize
이전 1 2 3 4 5 6 7 8 9 10 다음
Page: / 13349 Go >
RSS iconmap icon 
Instant Help